Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.
Announcement Eli Lilly and Company expressed its double excitement by confirming that it will be showcasing the new data from throughout its breast oncology portfolio and the robust pipeline at the ...
Announcement NervGen’s robust investigational peptide therapeutic, NVG-291, has successfully enhanced the quality of life and improved functional performance in a patient group having chronic ...
Announcement From July, several biotechs were forced to spin off as existing partnerships with the FDA around proofs needed for approval signalled a reversal. As per the experts, this will put the e...
Announcement The sceptical and the headlines creating a debate environment are spotting the cell and gene therapy area of late. The renewal of the efforts and that required motivation is not just wa...
Announcement iZafe Group has confirmed that it has signed a smart partnership deal with Vakt og Alarm. The Vakt og Alarm is one of Norway’s popular providers of alarm and safety services for t...
Announcement After getting near the end of the tunnel with the AAVantgarde closing of the Series B financing round, AGC Biologics is preparing for a new manufacturing agreement with the biotechnolog...
Announcement Concept Life Sciences, a known contract research organisation (CRO) delivering to the global pharma and Life Sciences industry, has proudly declared that it showcased three new research...
Announcement EVQLV has taken a step ahead in the AI-evolving world to accelerate its business and redefine the healthcare industry's potential values, best aligning with the tech world. The EVQL has...
Announcement OS Therapies Inc., the champion in listeria-related cancer immunotherapies, is near to offshoot OS Animal Health, Inc. (OSAH) into a standalone public company to be registered on a nati...
Announcement According to the Jefferies analysis, drugs that hold strong designations tend to pass the regulatory process more swiftly, thereby increasing their chances of success. Most of the FDA's...
Speak with a healthcare analyst about your research, consulting, or platform needs.